Baidu
map
J CEREBR BLOOD F MET 润色咨询

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

出版年份：1981 年文章数：3528 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：5.8% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=574596, encodeId=eed55e45969a, content=请问审稿流程分别用了多长时间<span class="quote">Coffeemaker 2018-07-02 11:16:00 发表:<br>发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.</span>, beContent=Coffeemaker 2018-07-02 11:16:00 发表: 发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e09e2138696, createdName=1381fe692am, createdTime=Fri Aug 09 00:00:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201916, encodeId=07b812019169a, content=审稿速度:2.0 | 投稿命中率:50.0 | 影响因子:6.2<br>偏重的研究方向：脑血流;脑梗塞<br>经验分享：投过三篇，一篇5天后被拒 一篇运气很好，8月23号投稿，9月15号通知小修，10月30号接收 另一篇8月10日投稿，9月14号通知大修，修了两个月，12月13号小修，1月13号接收 老牌杂志值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Sat Mar 12 09:36:12 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092697, encodeId=15b3109269e11, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092698, encodeId=4713109269833, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854673, encodeId=d30b8546e394, content=审稿速度:3.0<br>经验分享：经历两轮修改，从投稿至接收约9个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Sat Nov 02 12:49:56 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578699, encodeId=8a3b5e8699be, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563728, encodeId=45ee563e2899, content=请问status：Awaiting referee score是什么意思呀？<span class="quote">guoruoyi1 2018-11-24 发表::<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span><span class="quote">guoruoyi1 2018-11-24 00:00:00 发表:<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span>, beContent=guoruoyi1 2018-11-24 发表:: 效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=135b1436851, createdName=290624536, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563589, encodeId=e90456358933, content=效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Sat Nov 24 00:00:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558751, encodeId=341c558e5171, content=发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Mon Jul 02 11:16:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544174, encodeId=a1545441e4cb, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2019-08-09 1381fe692am

    请问审稿流程分别用了多长时间Coffeemaker 2018-07-02 11:16:00 发表:
    发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.

    Coffeemaker 2018-07-02 11:16:00 发表: 发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=574596, encodeId=eed55e45969a, content=请问审稿流程分别用了多长时间<span class="quote">Coffeemaker 2018-07-02 11:16:00 发表:<br>发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.</span>, beContent=Coffeemaker 2018-07-02 11:16:00 发表: 发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e09e2138696, createdName=1381fe692am, createdTime=Fri Aug 09 00:00:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201916, encodeId=07b812019169a, content=审稿速度:2.0 | 投稿命中率:50.0 | 影响因子:6.2<br>偏重的研究方向：脑血流;脑梗塞<br>经验分享：投过三篇，一篇5天后被拒 一篇运气很好，8月23号投稿，9月15号通知小修，10月30号接收 另一篇8月10日投稿，9月14号通知大修，修了两个月，12月13号小修，1月13号接收 老牌杂志值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Sat Mar 12 09:36:12 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092697, encodeId=15b3109269e11, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092698, encodeId=4713109269833, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854673, encodeId=d30b8546e394, content=审稿速度:3.0<br>经验分享：经历两轮修改，从投稿至接收约9个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Sat Nov 02 12:49:56 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578699, encodeId=8a3b5e8699be, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563728, encodeId=45ee563e2899, content=请问status：Awaiting referee score是什么意思呀？<span class="quote">guoruoyi1 2018-11-24 发表::<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span><span class="quote">guoruoyi1 2018-11-24 00:00:00 发表:<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span>, beContent=guoruoyi1 2018-11-24 发表:: 效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=135b1436851, createdName=290624536, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563589, encodeId=e90456358933, content=效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Sat Nov 24 00:00:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558751, encodeId=341c558e5171, content=发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Mon Jul 02 11:16:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544174, encodeId=a1545441e4cb, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2022-03-12 Coffeemaker

    审稿速度:2.0 | 投稿命中率:50.0 | 影响因子:6.2
    偏重的研究方向：脑血流;脑梗塞
    经验分享：投过三篇，一篇5天后被拒 一篇运气很好，8月23号投稿，9月15号通知小修，10月30号接收 另一篇8月10日投稿，9月14号通知大修，修了两个月，12月13号小修，1月13号接收 老牌杂志值得拥有

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=574596, encodeId=eed55e45969a, content=请问审稿流程分别用了多长时间<span class="quote">Coffeemaker 2018-07-02 11:16:00 发表:<br>发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.</span>, beContent=Coffeemaker 2018-07-02 11:16:00 发表: 发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e09e2138696, createdName=1381fe692am, createdTime=Fri Aug 09 00:00:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201916, encodeId=07b812019169a, content=审稿速度:2.0 | 投稿命中率:50.0 | 影响因子:6.2<br>偏重的研究方向：脑血流;脑梗塞<br>经验分享：投过三篇，一篇5天后被拒 一篇运气很好，8月23号投稿，9月15号通知小修，10月30号接收 另一篇8月10日投稿，9月14号通知大修，修了两个月，12月13号小修，1月13号接收 老牌杂志值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Sat Mar 12 09:36:12 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092697, encodeId=15b3109269e11, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092698, encodeId=4713109269833, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854673, encodeId=d30b8546e394, content=审稿速度:3.0<br>经验分享：经历两轮修改，从投稿至接收约9个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Sat Nov 02 12:49:56 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578699, encodeId=8a3b5e8699be, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563728, encodeId=45ee563e2899, content=请问status：Awaiting referee score是什么意思呀？<span class="quote">guoruoyi1 2018-11-24 发表::<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span><span class="quote">guoruoyi1 2018-11-24 00:00:00 发表:<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span>, beContent=guoruoyi1 2018-11-24 发表:: 效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=135b1436851, createdName=290624536, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563589, encodeId=e90456358933, content=效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Sat Nov 24 00:00:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558751, encodeId=341c558e5171, content=发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Mon Jul 02 11:16:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544174, encodeId=a1545441e4cb, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2021-12-28 小动量

    引言一般分几段？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=574596, encodeId=eed55e45969a, content=请问审稿流程分别用了多长时间<span class="quote">Coffeemaker 2018-07-02 11:16:00 发表:<br>发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.</span>, beContent=Coffeemaker 2018-07-02 11:16:00 发表: 发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e09e2138696, createdName=1381fe692am, createdTime=Fri Aug 09 00:00:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201916, encodeId=07b812019169a, content=审稿速度:2.0 | 投稿命中率:50.0 | 影响因子:6.2<br>偏重的研究方向：脑血流;脑梗塞<br>经验分享：投过三篇，一篇5天后被拒 一篇运气很好，8月23号投稿，9月15号通知小修，10月30号接收 另一篇8月10日投稿，9月14号通知大修，修了两个月，12月13号小修，1月13号接收 老牌杂志值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Sat Mar 12 09:36:12 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092697, encodeId=15b3109269e11, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092698, encodeId=4713109269833, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854673, encodeId=d30b8546e394, content=审稿速度:3.0<br>经验分享：经历两轮修改，从投稿至接收约9个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Sat Nov 02 12:49:56 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578699, encodeId=8a3b5e8699be, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563728, encodeId=45ee563e2899, content=请问status：Awaiting referee score是什么意思呀？<span class="quote">guoruoyi1 2018-11-24 发表::<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span><span class="quote">guoruoyi1 2018-11-24 00:00:00 发表:<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span>, beContent=guoruoyi1 2018-11-24 发表:: 效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=135b1436851, createdName=290624536, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563589, encodeId=e90456358933, content=效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Sat Nov 24 00:00:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558751, encodeId=341c558e5171, content=发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Mon Jul 02 11:16:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544174, encodeId=a1545441e4cb, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2021-12-27 MS68862005

    引言需要写什么内容？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=574596, encodeId=eed55e45969a, content=请问审稿流程分别用了多长时间<span class="quote">Coffeemaker 2018-07-02 11:16:00 发表:<br>发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.</span>, beContent=Coffeemaker 2018-07-02 11:16:00 发表: 发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e09e2138696, createdName=1381fe692am, createdTime=Fri Aug 09 00:00:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201916, encodeId=07b812019169a, content=审稿速度:2.0 | 投稿命中率:50.0 | 影响因子:6.2<br>偏重的研究方向：脑血流;脑梗塞<br>经验分享：投过三篇，一篇5天后被拒 一篇运气很好，8月23号投稿，9月15号通知小修，10月30号接收 另一篇8月10日投稿，9月14号通知大修，修了两个月，12月13号小修，1月13号接收 老牌杂志值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Sat Mar 12 09:36:12 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092697, encodeId=15b3109269e11, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092698, encodeId=4713109269833, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854673, encodeId=d30b8546e394, content=审稿速度:3.0<br>经验分享：经历两轮修改，从投稿至接收约9个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Sat Nov 02 12:49:56 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578699, encodeId=8a3b5e8699be, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563728, encodeId=45ee563e2899, content=请问status：Awaiting referee score是什么意思呀？<span class="quote">guoruoyi1 2018-11-24 发表::<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span><span class="quote">guoruoyi1 2018-11-24 00:00:00 发表:<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span>, beContent=guoruoyi1 2018-11-24 发表:: 效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=135b1436851, createdName=290624536, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563589, encodeId=e90456358933, content=效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Sat Nov 24 00:00:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558751, encodeId=341c558e5171, content=发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Mon Jul 02 11:16:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544174, encodeId=a1545441e4cb, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2019-11-02 ms4560175821706816

    审稿速度:3.0
    经验分享：经历两轮修改，从投稿至接收约9个月。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=574596, encodeId=eed55e45969a, content=请问审稿流程分别用了多长时间<span class="quote">Coffeemaker 2018-07-02 11:16:00 发表:<br>发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.</span>, beContent=Coffeemaker 2018-07-02 11:16:00 发表: 发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e09e2138696, createdName=1381fe692am, createdTime=Fri Aug 09 00:00:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201916, encodeId=07b812019169a, content=审稿速度:2.0 | 投稿命中率:50.0 | 影响因子:6.2<br>偏重的研究方向：脑血流;脑梗塞<br>经验分享：投过三篇，一篇5天后被拒 一篇运气很好，8月23号投稿，9月15号通知小修，10月30号接收 另一篇8月10日投稿，9月14号通知大修，修了两个月，12月13号小修，1月13号接收 老牌杂志值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Sat Mar 12 09:36:12 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092697, encodeId=15b3109269e11, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092698, encodeId=4713109269833, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854673, encodeId=d30b8546e394, content=审稿速度:3.0<br>经验分享：经历两轮修改，从投稿至接收约9个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Sat Nov 02 12:49:56 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578699, encodeId=8a3b5e8699be, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563728, encodeId=45ee563e2899, content=请问status：Awaiting referee score是什么意思呀？<span class="quote">guoruoyi1 2018-11-24 发表::<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span><span class="quote">guoruoyi1 2018-11-24 00:00:00 发表:<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span>, beContent=guoruoyi1 2018-11-24 发表:: 效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=135b1436851, createdName=290624536, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563589, encodeId=e90456358933, content=效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Sat Nov 24 00:00:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558751, encodeId=341c558e5171, content=发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Mon Jul 02 11:16:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544174, encodeId=a1545441e4cb, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    3个月

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=574596, encodeId=eed55e45969a, content=请问审稿流程分别用了多长时间<span class="quote">Coffeemaker 2018-07-02 11:16:00 发表:<br>发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.</span>, beContent=Coffeemaker 2018-07-02 11:16:00 发表: 发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e09e2138696, createdName=1381fe692am, createdTime=Fri Aug 09 00:00:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201916, encodeId=07b812019169a, content=审稿速度:2.0 | 投稿命中率:50.0 | 影响因子:6.2<br>偏重的研究方向：脑血流;脑梗塞<br>经验分享：投过三篇，一篇5天后被拒 一篇运气很好，8月23号投稿，9月15号通知小修，10月30号接收 另一篇8月10日投稿，9月14号通知大修，修了两个月，12月13号小修，1月13号接收 老牌杂志值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Sat Mar 12 09:36:12 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092697, encodeId=15b3109269e11, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092698, encodeId=4713109269833, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854673, encodeId=d30b8546e394, content=审稿速度:3.0<br>经验分享：经历两轮修改，从投稿至接收约9个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Sat Nov 02 12:49:56 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578699, encodeId=8a3b5e8699be, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563728, encodeId=45ee563e2899, content=请问status：Awaiting referee score是什么意思呀？<span class="quote">guoruoyi1 2018-11-24 发表::<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span><span class="quote">guoruoyi1 2018-11-24 00:00:00 发表:<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span>, beContent=guoruoyi1 2018-11-24 发表:: 效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=135b1436851, createdName=290624536, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563589, encodeId=e90456358933, content=效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Sat Nov 24 00:00:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558751, encodeId=341c558e5171, content=发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Mon Jul 02 11:16:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544174, encodeId=a1545441e4cb, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2018-11-28 290624536

    请问status：Awaiting referee score是什么意思呀？guoruoyi1 2018-11-24 发表::
    效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究    guoruoyi1 2018-11-24 00:00:00 发表:
    效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究

    guoruoyi1 2018-11-24 发表:: 效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=574596, encodeId=eed55e45969a, content=请问审稿流程分别用了多长时间<span class="quote">Coffeemaker 2018-07-02 11:16:00 发表:<br>发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.</span>, beContent=Coffeemaker 2018-07-02 11:16:00 发表: 发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e09e2138696, createdName=1381fe692am, createdTime=Fri Aug 09 00:00:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201916, encodeId=07b812019169a, content=审稿速度:2.0 | 投稿命中率:50.0 | 影响因子:6.2<br>偏重的研究方向：脑血流;脑梗塞<br>经验分享：投过三篇，一篇5天后被拒 一篇运气很好，8月23号投稿，9月15号通知小修，10月30号接收 另一篇8月10日投稿，9月14号通知大修，修了两个月，12月13号小修，1月13号接收 老牌杂志值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Sat Mar 12 09:36:12 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092697, encodeId=15b3109269e11, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092698, encodeId=4713109269833, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854673, encodeId=d30b8546e394, content=审稿速度:3.0<br>经验分享：经历两轮修改，从投稿至接收约9个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Sat Nov 02 12:49:56 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578699, encodeId=8a3b5e8699be, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563728, encodeId=45ee563e2899, content=请问status：Awaiting referee score是什么意思呀？<span class="quote">guoruoyi1 2018-11-24 发表::<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span><span class="quote">guoruoyi1 2018-11-24 00:00:00 发表:<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span>, beContent=guoruoyi1 2018-11-24 发表:: 效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=135b1436851, createdName=290624536, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563589, encodeId=e90456358933, content=效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Sat Nov 24 00:00:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558751, encodeId=341c558e5171, content=发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Mon Jul 02 11:16:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544174, encodeId=a1545441e4cb, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2018-11-24 guoruoyi1

    效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=574596, encodeId=eed55e45969a, content=请问审稿流程分别用了多长时间<span class="quote">Coffeemaker 2018-07-02 11:16:00 发表:<br>发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.</span>, beContent=Coffeemaker 2018-07-02 11:16:00 发表: 发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e09e2138696, createdName=1381fe692am, createdTime=Fri Aug 09 00:00:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201916, encodeId=07b812019169a, content=审稿速度:2.0 | 投稿命中率:50.0 | 影响因子:6.2<br>偏重的研究方向：脑血流;脑梗塞<br>经验分享：投过三篇，一篇5天后被拒 一篇运气很好，8月23号投稿，9月15号通知小修，10月30号接收 另一篇8月10日投稿，9月14号通知大修，修了两个月，12月13号小修，1月13号接收 老牌杂志值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Sat Mar 12 09:36:12 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092697, encodeId=15b3109269e11, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092698, encodeId=4713109269833, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854673, encodeId=d30b8546e394, content=审稿速度:3.0<br>经验分享：经历两轮修改，从投稿至接收约9个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Sat Nov 02 12:49:56 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578699, encodeId=8a3b5e8699be, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563728, encodeId=45ee563e2899, content=请问status：Awaiting referee score是什么意思呀？<span class="quote">guoruoyi1 2018-11-24 发表::<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span><span class="quote">guoruoyi1 2018-11-24 00:00:00 发表:<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span>, beContent=guoruoyi1 2018-11-24 发表:: 效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=135b1436851, createdName=290624536, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563589, encodeId=e90456358933, content=效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Sat Nov 24 00:00:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558751, encodeId=341c558e5171, content=发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Mon Jul 02 11:16:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544174, encodeId=a1545441e4cb, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2018-07-02 Coffeemaker

    发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=574596, encodeId=eed55e45969a, content=请问审稿流程分别用了多长时间<span class="quote">Coffeemaker 2018-07-02 11:16:00 发表:<br>发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收.</span>, beContent=Coffeemaker 2018-07-02 11:16:00 发表: 发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=193, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e09e2138696, createdName=1381fe692am, createdTime=Fri Aug 09 00:00:00 CST 2019, time=2019-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201916, encodeId=07b812019169a, content=审稿速度:2.0 | 投稿命中率:50.0 | 影响因子:6.2<br>偏重的研究方向：脑血流;脑梗塞<br>经验分享：投过三篇，一篇5天后被拒 一篇运气很好，8月23号投稿，9月15号通知小修，10月30号接收 另一篇8月10日投稿，9月14号通知大修，修了两个月，12月13号小修，1月13号接收 老牌杂志值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Sat Mar 12 09:36:12 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092697, encodeId=15b3109269e11, content=引言一般分几段？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092698, encodeId=4713109269833, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854673, encodeId=d30b8546e394, content=审稿速度:3.0<br>经验分享：经历两轮修改，从投稿至接收约9个月。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd975414106, createdName=ms4560175821706816, createdTime=Sat Nov 02 12:49:56 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578699, encodeId=8a3b5e8699be, content=3个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563728, encodeId=45ee563e2899, content=请问status：Awaiting referee score是什么意思呀？<span class="quote">guoruoyi1 2018-11-24 发表::<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span><span class="quote">guoruoyi1 2018-11-24 00:00:00 发表:<br>效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究</span>, beContent=guoruoyi1 2018-11-24 发表:: 效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, objectType=tool_impact_factor, channel=null, level=null, likeNumber=286, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=135b1436851, createdName=290624536, createdTime=Wed Nov 28 00:00:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563589, encodeId=e90456358933, content=效率很高，投稿两天被编辑部拒了。。我投的是一个卒中方面的小样本临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23571996062, createdName=guoruoyi1, createdTime=Sat Nov 24 00:00:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558751, encodeId=341c558e5171, content=发表的第一篇SCI.速度比我想象的快.8月23号投出.一个月后小修.10月30日接收., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=376, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/09/d664eb5383511ad5e96b0b88bac0cbb9.jpg, createdBy=89c61782685, createdName=Coffeemaker, createdTime=Mon Jul 02 11:16:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544174, encodeId=a1545441e4cb, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]
    2017-07-16 yangbin2015

    过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了.

    0

共18条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map